Related Experiment Videos
Salmonella group-E (Senftenberg) lung abscess: a case report
J P Gupta1, P B Borkar, P Durairaj
1Department of Respiratory Medicine, JLN Hospital, Bhilai.
The Indian Journal of Chest Diseases & Allied Sciences
|April 1, 1994
Summary
A lung abscess caused by Salmonella group E infection was successfully treated with cefotaxime. This highlights the importance of targeted antibiotic therapy for specific bacterial infections.
Area of Science:
- Infectious Diseases
- Pulmonology
- Microbiology
Background:
- A male patient presented with symptoms including fever, cough, and gastrointestinal distress.
- Imaging revealed a lung abscess in the left mid zone, indicating a serious pulmonary infection.
Observation:
- Initial empirical antibiotic treatment with ampicillin and gentamycin proved ineffective.
- Cultures identified Salmonella group E as the causative agent, resistant to initial antibiotics.
Findings:
- The patient showed significant clinical and radiological improvement after treatment with intravenous cefotaxime.
- Bacteriological clearance confirmed the efficacy of cefotaxime against the Salmonella group E infection.
Implications:
- This case underscores the necessity of microbiological culture and sensitivity testing for effective treatment of complex infections.
- Targeted antibiotic therapy, such as with cefotaxime, is crucial for managing antibiotic-resistant bacterial infections like Salmonella group E.
- Early and accurate diagnosis can prevent treatment failure and improve patient outcomes in cases of lung abscess.